News from European Hematology Association A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages.


May 19, 2016, 16:05 ET Celator® Pharmaceuticals Announces Upcoming Phase 3 Data Presentations at American Society of Clinical Oncology (ASCO) and European Hematology Association (EHA)

 Celator Pharmaceuticals, Inc. (Nasdaq:CPXX) today announced that Phase 3 clinical trial data for VYXEOS™ (cytarabine:daunorubicin)...